Atara Biotherapeutics (ATRA) Cash & Equivalents (2013 - 2026)
Atara Biotherapeutics' Cash & Equivalents was $3.22 million in Q2 2026, down 80.9% from $16.9 million a year earlier and down 61.7% from the prior quarter.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Cash & Equivalents (2013 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Atara Biotherapeutics came in at $8.48 million, down 66.1% from FY2024.
- Cash & Equivalents has now declined for five consecutive years, with a five-year compound annual growth rate of -46.9% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $25.03 million in FY2024 (-3.1%), $25.84 million in FY2023 (-72.2%), $92.94 million in FY2022 (-12.4%) and $106.08 million in FY2021 (-47.1%).
- The Q2 2026 figure marks the lowest quarterly Cash & Equivalents in data going back to Q3 2013.
- Compared with a year earlier, Cash & Equivalents has declined for 19 straight quarters, with an average decline of 51.5% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q3 2021 (growth of 80.8%); the worst was Q3 2025 (a decline of 87.6%).
- Per Business Quant data, ATRA's Cash & Equivalents in the three quarters before Q2 2026 was $8.4 million (Q1 2026), $8.48 million (Q4 2025) and $5.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Atara Biotherapeutics | 127.18 Mn | 117.28 Mn | 439,000.00 | 3.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.22 Mn |
| Mar 31, 2026 | 8.40 Mn |
| Dec 31, 2025 | 8.48 Mn |
| Sep 30, 2025 | 5.74 Mn |
| Jun 30, 2025 | 16.90 Mn |
| Mar 31, 2025 | 13.84 Mn |
| Dec 31, 2024 | 25.03 Mn |
| Sep 30, 2024 | 46.45 Mn |
| Jun 30, 2024 | 31.31 Mn |
| Mar 31, 2024 | 35.09 Mn |
| Dec 31, 2023 | 25.84 Mn |
| Sep 30, 2023 | 64.79 Mn |
| Jun 30, 2023 | 45.90 Mn |
| Mar 31, 2023 | 48.74 Mn |
| Dec 31, 2022 | 92.94 Mn |
| Sep 30, 2022 | 65.11 Mn |
| Jun 30, 2022 | 70.69 Mn |
| Mar 31, 2022 | 101.67 Mn |
| Dec 31, 2021 | 106.08 Mn |
| Sep 30, 2021 | 113.21 Mn |
API Access
Atara Biotherapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();